![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. Combivir
2. Lamivudine, Zidovudine Drug Combination
1. Lamivudine + Zidovudine
2. 165456-81-5
3. 4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2r,4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
4. Lamivudine; Zidovudine
5. Zidovudine / Lamivudine
6. Lamivudine / Zidovudine
7. Lamivudine, Zidovudine Drug Combination
8. 3tc / Zdv
9. Combivir(tm)
10. Lamivudine Mixture With Zidovudine
11. Zidovudine Mixture With Lamivudine
12. Epivir & Retrovir
13. 4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one; 1-[(2r,4s,5s)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
14. Mixture Of Lamivudine And Zidovudine
15. Lamivudine & Zidovudine
16. 3tc & Zdv
17. Azt & 3tc & Sst
18. (-)-3tc & Azt
19. .beta.-l-(-)-2',3'-dideoxy-3'-thiacytidine & 3'-azido-3'-deoxythymidine
20. .beta.-l-(-)-2',3'-dideoxy-3'-thiacytidine & 3'-azido-3'-deoxythymidine & Sho-saiko-to
21. Thymidine, 3'-azido-3'-deoxy-, Mixt. With 4-amino-1-((2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1h)-pyrimidinone
Molecular Weight | 496.5 g/mol |
---|---|
Molecular Formula | C18H24N8O7S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 5 |
Exact Mass | 496.14886631 g/mol |
Monoisotopic Mass | 496.14886631 g/mol |
Topological Polar Surface Area | 207 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 815 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Lamivudine and zidovudine |
Drug Label | COMBIVIR: COMBIVIR Tablets are combination tablets containing lamivudine and zidovudine. Lamivudine (EPIVIR) and zidovudine (RETROVIR, azidothymidine, AZT, or ZDV) are synthetic nucleoside analogues with activity against HIV-1.COMBIVIR Tablets are fo... |
Active Ingredient | Lamivudine and zidovudine; Lamivudine; zidovudine |
Dosage Form | Tablet |
Route | oral; Oral |
Strength | 150mg; 300mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Hetero Labs Ltd V; Aurobindo Pharma; Lupin; Teva Pharms; Strides Arcolab |
2 of 4 | |
---|---|
Drug Name | Lamivudine; zidovudine |
Active Ingredient | efavirenz; Lamivudine; zidovudine |
Dosage Form | Tablet, for suspension; Tablet |
Route | oral; oral suspension |
Strength | 60mg; 30mg; 150mg; 600mg; 300mg |
Market Status | Tentative Approval |
Company | Macleods Pharma; Hetero Drugs; Aurobindo; Mylan Labs; Aurobindo Pharma; Cipla; Pharmacare; Matrix Labs; Emcure Pharma |
3 of 4 | |
---|---|
Drug Name | Lamivudine and zidovudine |
Drug Label | COMBIVIR: COMBIVIR Tablets are combination tablets containing lamivudine and zidovudine. Lamivudine (EPIVIR) and zidovudine (RETROVIR, azidothymidine, AZT, or ZDV) are synthetic nucleoside analogues with activity against HIV-1.COMBIVIR Tablets are fo... |
Active Ingredient | Lamivudine and zidovudine; Lamivudine; zidovudine |
Dosage Form | Tablet |
Route | oral; Oral |
Strength | 150mg; 300mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Hetero Labs Ltd V; Aurobindo Pharma; Lupin; Teva Pharms; Strides Arcolab |
4 of 4 | |
---|---|
Drug Name | Lamivudine; zidovudine |
Active Ingredient | efavirenz; Lamivudine; zidovudine |
Dosage Form | Tablet, for suspension; Tablet |
Route | oral; oral suspension |
Strength | 60mg; 30mg; 150mg; 600mg; 300mg |
Market Status | Tentative Approval |
Company | Macleods Pharma; Hetero Drugs; Aurobindo; Mylan Labs; Aurobindo Pharma; Cipla; Pharmacare; Matrix Labs; Emcure Pharma |
Anti-HIV Agents
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)
Reverse Transcriptase Inhibitors
Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)